Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...
In Vitro Effects of 2-{4-[Methylthio(methylsulfonyl)]phenyl}-3-substitutedthiazolidin-4-ones on the Acetylcholinesterase Activity in Rat Brain and Lymphocytes: Isoform Selectivity, Kinetic Analysis, and Molecular Docking
This work evaluated the in vitro effect of thiazolidin-4-ones on the activity of AChE (total and isoforms) isolated from the cerebral cortex, hippocampus, and lymphocytes. Kinetic parameters were evaluated and molecular docking was performed. Our results showed that thiazolidinones derived from 4-(methylthio)benzaldehyde (
1
) and from 4-(methylsulfonyl)benzaldehyde (
2
) were capable of inhibiting the AChE activity in vitro. Three compounds, two with a propylpiperidine (
1b
and
2b
) moiety and one with a 3-(diethylamino)propyl (
1c
) moiety showed IC
50
values of 13.81 μM, and 3.13 μM (
1b
), 55.36 μM and 44.33 μM (
1c
) for cerebral cortex and hippocampus, respectively, and 3.11 μM for both (
2b
). Enzyme kinetics revealed that the type of AChE inhibition was mixed. Compound
1b
inhibited the G1 and G4 AChE isoforms, while compounds
1c
and
2b
selectively inhibited the G4 isoform. Molecular docking showed a possible three-dimensional fit into the enzyme. Our findings showed that these thiazolidin-4-ones, especially those containing the propylpiperidine core, have a potential cholinesterase inhibitory activity and can be considered good candidates for future Alzheimer’s therapy.